# Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)

> **NCT00383435** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1055 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Mometasone furoate/formoterol (MF/F) combination
- **DRUG:** Mometasone furoate/formoterol (MF/F) combination
- **DRUG:** Mometasone furoate MDI (MF MDI)
- **DRUG:** Formoterol MDI
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00383435
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 1055 (ACTUAL)
- **Last updated:** 2024-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383435, "Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00383435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*